Get the Stockscreener App
10.11
0.05%
0.005
After Hours:
10.11
0.005
+0.05%
Drugs Made In America Acquisition Ii Corp stock is traded at $10.11, with a volume of 80,439.
It is up +0.05% in the last 24 hours and up +0.55% over the past month.
Drugs Made In America Acquisition II Corp is a blank check Company.
See More
Previous Close:
$10.10
Open:
$10.1
24h Volume:
80,439
Relative Volume:
0.62
Market Cap:
$643.69M
Revenue:
-
Net Income/Loss:
$8.58M
P/E Ratio:
75.41
EPS:
0.134
Net Cash Flow:
$-1.11M
1W Performance:
+0.15%
1M Performance:
+0.55%
6M Performance:
+1.46%
1Y Performance:
+0.00%
1-Day Range:
$10.10
$10.11
1-Week Range:
$10.08
$10.11
52-Week Range:
$9.87
$10.11
Drugs Made In America Acquisition Ii Corp Stock (DMII) Company Profile
Name
Drugs Made In America Acquisition Ii Corp
Sector
Industry
Phone
954-870-3104
Address
420 LEXINGTON AVENUE, NEW YORK
Compare DMII vs LION, XXI, UMAC, CCXI
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
DMII
Drugs Made In America Acquisition Ii Corp
|
10.11 | 643.37M | 0 | 8.58M | -1.11M | 0.134 |
LION
Lionsgate Studios Corp
|
13.27 | 3.88B | 2.63B | -175.60M | 11.40M | -0.7173 |
XXI
Twenty One Capital Inc
|
4.53 | 1.57B | 0 | 4.35M | 456.40K | 0.3397 |
UMAC
Unusual Machines Inc
|
20.60 | 925.29M | 17.25M | -5.64M | -40.16M | -0.3337 |
CCXI
Churchill Capital Corp Xi
|
13.72 | 761.98M | 0 | 0 | 0 | 0.0647 |
Drugs Made In America Acquisition Ii Corp Stock (DMII) Latest News
Drugs Made In America Acquisition II Ord Shs (DMII) Cash Flow - TradingKey
Drugs Made In America Acquisition Corp (DMAA) Valuation: PE, PB & Fair Value Analysis - TradingKey
Drugs Made In America Acquisition Corp - TradingKey
Drugs Made In America Acquisition II Ord Shs (DMII) Institutional Confidence - TradingKey
162,795 Shares in Drugs Made In America Acquisition Corp. $DMAA Purchased by Sona Asset Management US LLC - MarketBeat
DMII|Drugs Made In America Acquisition II Ord Shs|Price:10.100|Chg%:-0.005 - TradingKey
Drugs Made In America Acquisition II Ord Shs (DMII) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Drugs Made In America Acquisition II Ord Shs (DMII) Valuation: PE, PB & Fair Value Analysis - TradingKey
Drugs Made In America Acquisition II Ord Shs (DMII) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
TradingKey - TradingKey
Drugs Made In America Acquisition Corp (DMAA) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
QETA|Quetta Acquisition Corp|Price:11.430| - TradingKey
BLUW|Blue Water Acquisition Corp III|Price:10.340|Chg%:+0.010 - TradingKey
DRDB|Roman DBDR Acquisition Corp II|Price:10.585|Chg%:-0.020 - TradingKey
Drugs Made In America Acquisition II Corp. Revenue Breakdown – NASDAQ:DMII - TradingView
CAPN|Cayson Acquisition Corp|Price:11.100|Chg%:-0.050 - TradingKey
RIBB|RIBB|Price:10.810| - TradingKey
Drugs Made In America Acquisition II Ord Shs (DMII) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Drugs Made In America Acquisition Corp (DMAA) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Drugs Made In America Acquisition Corp (DMAA) Cash Flow - TradingKey
Drugs Made In America Acquisition Corp (DMAA) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
DMAA|Drugs Made In America Acquisition Corp|Price:10.700|Chg%:-0.020 - TradingKey
Drugs Made In America Acquisition Corp (DMAA) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
DMAA|Drugs Made In America Acquisition Corp|Price:10.700| - TradingKey
DMAA|Drugs Made In America Acquisition Corp|Price:10.709|Chg%:+0.009 - TradingKey
PLMK|Plum Acquisition Corp. IV|Price:10.610| - TradingKey
DMAA|Drugs Made In America Acquisition Corp|Price:10.681|Chg%:-0.009 - TradingKey
IBAC|IB Acquisition Corp|Price:10.730|Chg%:-0.060 - TradingKey
JENA|Jena Acquisition Corp II|Price:10.500|Chg%:+0.090 - TradingKey
WTG|Wintergreen Acquisition Corp|Price:10.475|Chg%:+0.005 - TradingKey
MYX|Maywood Acquisition 2 Ord Shs Class A|Price:9.925|Chg%:-0.005 - TradingKey
DMII|Drugs Made In America Acquisition II Ord Shs|Price:10.095|Chg%:+0.005 - TradingKey
GSHR|Gesher Acquisition II Corp|Price:10.470|Chg%:-0.030 - TradingKey
Eli Lilly and Company - Encyclopedia Britannica
$HAREHOLDER ALERT: The M&A Class Action Firm Announces An Investigation of Drugs Made In America Acquisition Corp. (NASDAQ: DMAA) - PR Newswire
Drugs Made In America amends merger agreement terms - TipRanks
Drugs Made In America Acquisition Revises PAGC Merger; Sets $30M Target Cash and Founder Share Forfeiture - TradingView
Pfizer Inc. | Pharmaceuticals, Vaccines & Company History | Britannica Money - Encyclopedia Britannica
Price to book forward of Drugs Made In America Acquisition Corp. – NASDAQ:DMAA - TradingView
Price to sales forward of Drugs Made In America Acquisition Corp. – NASDAQ:DMAA - TradingView
Enterprise value to EBIT forward of Drugs Made In America Acquisition Corp. – NASDAQ:DMAA - TradingView
Layoff Tracker: EMD Serono may trim R&D workforce by up to 70 - BioSpace
Drugs Made In America Acquisition Corp. Rights (DMAAR) Hold Steady at $0.10 Amid Low ActivityRetail Sentiment - dars.gov.et
Drugs Made In America Acquisition (NASDAQ:DMAA) Trading Down 0.1%Here's What Happened - MarketBeat
Price to sales forward of Drugs Made In America Acquisition II Corp. – BOATS:DMIIU - TradingView
Price to earnings forward of Drugs Made In America Acquisition II Corp. – BOATS:DMIIU - TradingView
HSLV Q2 2026 Earnings: Massive EPS Surprise Despite No Reported RevenueCFO Commentary Report - dars.gov.et
Enterprise value to EBIT forward of Drugs Made In America Acquisition II Corp. – BOATS:DMIIU - TradingView
Price to book forward of Drugs Made In America Acquisition Corp. – NASDAQ:DMAAU - TradingView
OACCU Stock Fund Price and Chart — NASDAQ:OACCU - TradingView
Drugs Made In America Acquisition Corp. Rights (DMAAR) Edges Higher in Thin TradingDouble EMA - dars.gov.et
Drugs Made In America Acquisition Ii Corp Stock (DMII) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.00%
0.92%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):